BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 36 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $690,000 | +2.2% | 657,000 | 0.0% | 0.00% | – |
| Q1 2018 | $675,000 | -5.7% | 657,000 | 0.0% | 0.00% | – |
| Q4 2017 | $716,000 | -2.6% | 657,000 | 0.0% | 0.00% | – |
| Q3 2017 | $735,000 | +0.4% | 657,000 | -0.5% | 0.00% | – |
| Q2 2017 | $732,000 | -2.3% | 660,000 | 0.0% | 0.00% | – |
| Q1 2017 | $749,000 | +0.7% | 660,000 | 0.0% | 0.00% | – |
| Q4 2016 | $744,000 | -8.1% | 660,000 | 0.0% | 0.00% | – |
| Q3 2016 | $810,000 | -42.2% | 660,000 | -47.6% | 0.00% | – |
| Q2 2016 | $1,402,000 | -2.8% | 1,260,000 | 0.0% | 0.00% | – |
| Q1 2016 | $1,443,000 | +11.2% | 1,260,000 | +24.8% | 0.00% | – |
| Q4 2015 | $1,298,000 | +2.2% | 1,010,000 | +0.3% | 0.00% | – |
| Q3 2015 | $1,270,000 | -44.3% | 1,007,000 | -33.2% | 0.00% | -100.0% |
| Q2 2015 | $2,280,000 | +2.2% | 1,507,000 | -0.4% | 0.00% | 0.0% |
| Q1 2015 | $2,232,000 | -16.4% | 1,513,000 | -33.1% | 0.00% | 0.0% |
| Q4 2014 | $2,671,000 | +0.4% | 2,263,000 | -9.9% | 0.00% | 0.0% |
| Q3 2014 | $2,660,000 | -49.0% | 2,513,000 | -49.9% | 0.00% | 0.0% |
| Q2 2014 | $5,212,000 | +90.9% | 5,014,000 | +100.5% | 0.00% | 0.0% |
| Q1 2014 | $2,730,000 | -13.3% | 2,501,000 | -15.2% | 0.00% | 0.0% |
| Q4 2013 | $3,149,000 | – | 2,950,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|